Search Orphan Drug Designations and Approvals
-
Generic Name: | bispecific T-cell engager (BiTE) antibody targeting CD33 and CD3 |
---|---|
Date Designated: | 07/01/2019 |
Orphan Designation: | Treatment of Acute Myeloid Leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amgen Inc. One Amgen Center Drive Mail Stop 17-1-A Thousand Oaks, California 91320 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-